Natural Killer Cells Therapeutics Market Size, Growth, Report 2027

Summary

Report Description

The global natural killer cells therapeutics market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to growing patient pool suffering from various chronic diseases such as cancer, cardiovascular diseases, diabetes, among others. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This has increased the demand for effective treatment options for finding a cure for cancer, thereby driving the growth of global natural killer cells therapeutics market. Additionally, growing focus of biotechnology & pharmaceutical companies and academic & research institutions across the globe for developing cost effective and potent treatments for different chronic diseases is expected to create lucrative opportunities for the market growth in the coming years. These companies and research organizations are conducting research & development activities and launching clinical trials in search of a potential natural killer cells therapeutics solution for different chronic and acute diseases. According, to clinicaltrials.gov, there are around 199 clinical trials related to natural killer cells are in some phase of development worldwide.

Application of the Natural Killer Cells in Treatment of Critical Diseases

Increasing application of natural killer cells for the treatment of various disease including liver diseases, infections, cancer, among others is expected to drive the growth of global natural killer cells therapeutics market in the forecast period. In addition to this, the natural killer cells play a pivotal role in the immune surveillance of tumor. This in turn is leading to the widespread adoption of natural killer cells therapeutics across the world. Besides, natural killer cells have specific attaching ability and ability to discard stressed cells. All these benefits associated with natural killer cells is expected to drive the growth of global natural killer cells therapeutics market during the forecast period.

Rise in Awareness about Immunotherapies

The prevalence of cancer has increased worldwide over the years and the available treatment options are not that efficient since a lot of instances of reoccurrence of tumours has been witnessed, arising the need for development of an effective and permanent treatment. Immunotherapies have gained much attention in recent years to treat different malignancies. Among all the immunotherapies, CAR –T cell therapies have been studied and were used but have various limitations that led to the development of natural killer (NK) cell therapies. Growing the awareness among the population about various immunotherapies and increase in research and development of bi-specific antibody for engaging natural killer cells to eliminate tumor cells are driving the global natural killer (NK) cell therapeutics market.

Download Free Sample Report

Market Segmentation

The global natural killer cells therapeutics market can be segmented by type, by application, by end use, and by region. Based on type, the market can be segmented into natural killer cell therapies and natural killer cell directed antibodies. Based on application, the market can be differentiated into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. Based on end user, the market can be categorized into hospitals & clinics, academic & research institutions, and others. Regionally, North America dominated the global natural killer cells therapeutics market followed by Europe, Asia Pacific, South America, and Middle East & Africa region. In terms of countries, United States dominated the global natural killer cells therapeutics market in 2021 and is expected to maintain its dominance during the forecast period on account of growing prevalence of different chronic diseases in the country. According to the global cancer observatory, around 2,281,658 new cancer cases were reported in the United States in 2020.

Market Players

Affimed N.V., Century Therapeutics, Inc., Celularity Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., Fate Therapeutics, Inc., Gamida Cell Ltd., ImmunityBio, Inc., Innate Pharma SA , Nkarta, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited , VaxCell Biotherapeutics Co., Ltd., Acepodia Inc., Glycostem Therapeutics B.V., among others are some of the leading players operating in the global natural killer cells therapeutics market.

Attribute	Details
Base Year	2021
Historic Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· By Type · By Application · By End User · By Region
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Turkey; Egypt
Key companies profiled	Affimed N.V., Century Therapeutics, Inc., Celularity Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., Fate Therapeutics, Inc., Gamida Cell Ltd., ImmunityBio, Inc., Innate Pharma SA , Nkarta, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited , VaxCell Biotherapeutics Co., Ltd., Acepodia Inc., Glycostem Therapeutics B.V.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global natural killer cells therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Natural Killer Cells Therapeutics Market, By Type:

o Natural Killer Cell Therapies
o Natural Killer Cell Directed Antibodies

Natural Killer Cells Therapeutics Market, By Application:

o Cancer

o Gastrointestinal Diseases

o Immunoproliferative Disorders

o Others

·         Natural Killer Cells Therapeutics Market, By End User:

                    o Hospitals & Clinics
                    o Academic & Research Institutions
                    o Others

· Natural Killer Cells Therapeutics Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ Germany

§ United Kingdom

§ Italy

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ South Korea

§ Australia

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Turkey

§ Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Natural Killer Cells Therapeutics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Natural Killer Cells Therapeutics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Natural Killer Cells Therapeutics Market

5. Voice of Customer

6. Clinical Trial Analysis

7. Global Natural Killer Cells Therapeutics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies)

7.2.2. By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others)

7.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)

7.2.4. By Region

7.2.5. By Company (2021)

7.3. Market Map

8. North America Natural Killer Cells Therapeutics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By Application

8.2.3. By End User

8.2.4. By Country

8.3. North America: Country Analysis

8.3.1. United States Natural Killer Cells Therapeutics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. By Application

8.3.1.2.3. By End User

8.3.2. Canada Natural Killer Cells Therapeutics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. By Application

8.3.2.2.3. By End User

8.3.3. Mexico Natural Killer Cells Therapeutics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. By Application

8.3.3.2.3. By End User

9. Europe Natural Killer Cells Therapeutics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type

9.2.2. By Application

9.2.3. By End User

9.2.4. By Country

9.3. Europe: Country Analysis

9.3.1. France Natural Killer Cells Therapeutics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. By Application

9.3.1.2.3. By End User

9.3.2. Germany Natural Killer Cells Therapeutics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. By Application

9.3.2.2.3. By End User

9.3.3. United Kingdom Natural Killer Cells Therapeutics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. By Application

9.3.3.2.3. By End User

9.3.4. Italy Natural Killer Cells Therapeutics Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Type

9.3.4.2.2. By Application

9.3.4.2.3. By End User

9.3.5. Spain Natural Killer Cells Therapeutics Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Type

9.3.5.2.2. By Application

9.3.5.2.3. By End User

10. Asia-Pacific Natural Killer Cells Therapeutics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type

10.2.2. By Application

10.2.3. By End User

10.2.4. By Country

10.3. Asia-Pacific: Country Analysis

10.3.1. China Natural Killer Cells Therapeutics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. By Application

10.3.1.2.3. By End User

10.3.2. India Natural Killer Cells Therapeutics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. By Application

10.3.2.2.3. By End User

10.3.3. Japan Natural Killer Cells Therapeutics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. By Application

10.3.3.2.3. By End User

10.3.4. South Korea Natural Killer Cells Therapeutics Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Type

10.3.4.2.2. By Application

10.3.4.2.3. By End User

10.3.5. Australia Natural Killer Cells Therapeutics Market Outlook

10.3.5.1. Market Size & Forecast

10.3.5.1.1. By Value

10.3.5.2. Market Share & Forecast

10.3.5.2.1. By Type

10.3.5.2.2. By Application

10.3.5.2.3. By End User

11. South America Natural Killer Cells Therapeutics Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Type

11.2.2. By Application

11.2.3. By End User

11.2.4. By Country

11.3. South America: Country Analysis

11.3.1. Brazil Natural Killer Cells Therapeutics Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Type

11.3.1.2.2. By Application

11.3.1.2.3. By End User

11.3.2. Argentina Natural Killer Cells Therapeutics Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Type

11.3.2.2.2. By Application

11.3.2.2.3. By End User

11.3.3. Colombia Natural Killer Cells Therapeutics Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Type

11.3.3.2.2. By Application

11.3.3.2.3. By End User

12. Middle East and Africa Natural Killer Cells Therapeutics Market Outlook

12.1. Market Size & Forecast

12.1.1. By Value

12.2. Market Share & Forecast

12.2.1. By Type

12.2.2. By Application

12.2.3. By End User

12.2.4. By Country

12.3. MEA: Country Analysis

12.3.1. South Africa Natural Killer Cells Therapeutics Market Outlook

12.3.1.1. Market Size & Forecast

12.3.1.1.1. By Value

12.3.1.2. Market Share & Forecast

12.3.1.2.1. By Type

12.3.1.2.2. By Application

12.3.1.2.3. By End User

12.3.2. Saudi Arabia Natural Killer Cells Therapeutics Market Outlook

12.3.2.1. Market Size & Forecast

12.3.2.1.1. By Value

12.3.2.2. Market Share & Forecast

12.3.2.2.1. By Type

12.3.2.2.2. By Application

12.3.2.2.3. By End User

12.3.3. UAE Natural Killer Cells Therapeutics Market Outlook

12.3.3.1. Market Size & Forecast

12.3.3.1.1. By Value

12.3.3.2. Market Share & Forecast

12.3.3.2.1. By Type

12.3.3.2.2. By Application

12.3.3.2.3. By End User

12.3.4. Turkey Natural Killer Cells Therapeutics Market Outlook

12.3.4.1. Market Size & Forecast

12.3.4.1.1. By Value

12.3.4.2. Market Share & Forecast

12.3.4.2.1. By Type

12.3.4.2.2. By Application

12.3.4.2.3. By End User

12.3.5. Egypt Natural Killer Cells Therapeutics Market Outlook

12.3.5.1. Market Size & Forecast

12.3.5.1.1. By Value

12.3.5.2. Market Share & Forecast

12.3.5.2.1. By Type

12.3.5.2.2. By Application

12.3.5.2.3. By End User

13. Market Dynamics

13.1. Drivers

13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

15.1. Affimed N.V.

15.2. Century Therapeutics, Inc.

15.3. Celularity Inc.

15.4. Cytovac A/S

15.5. Dragonfly Therapeutics, Inc.

15.6. Fate Therapeutics, Inc.

15.7. Gamida Cell Ltd.

15.8. ImmunityBio, Inc.

15.9. Innate Pharma SA

15.10. Nkarta, Inc.

15.11. Sanofi S.A.

15.12. Takeda Pharmaceutical Company Limited

15.13. VaxCell Biotherapeutics Co., Ltd.

15.14. Acepodia Inc.

15.15. Glycostem Therapeutics B.V.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Natural Killer Cells Therapeutics Market?

Rising prevalence of chronic disease like cancer, increasing investment in research and development sector, among others are some of the factors driving the growth of global natural killer cells therapeutics market.

Who are the top players operating in the Natural Killer Cells Therapeutics Market?

Affimed N.V., Century Therapeutics, Inc., Celularity Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., Fate Therapeutics, Inc., Gamida Cell Ltd., ImmunityBio, Inc., Innate Pharma SA , Nkarta, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited , VaxCell Biotherapeutics Co., Ltd., Acepodia Inc., Glycostem Therapeutics B.V are some of the leading players operating in the global natural killer cells therapeutics market.

Which type is expected to dominate the Global Natural Killer Cells Therapeutics Market in the forecast period?

Natural killer cell antibodies segment type is expected to dominate global natural killer cells therapeutics market during the forecast period.

Which region is expected to account for the largest share in the Global Natural Killer Cells Therapeutics Market?

North America region is estimated to hold the largest share in the global natural killer cells therapeutics market during the forecast period.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Global Natural Killer Cells Therapeutics Market to Be Dominated by Natural Killer Cell Directed Antibodies Segment Through 2027

Sep, 2022

Increasing prevalence of chronic diseases such as cancer is expected to drive the growth of global natural killer cells therapeutics market in the forecast period, 2023-2027.

Buy Now